Xiaoling Wang
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- RNA Interference and Gene Delivery
- RNA Research and Splicing
- Extracellular vesicles in disease
- Genomics and Chromatin Dynamics
Papers in
-
- Retinoids in leukemia and cellular processes 4
- Genomics and Chromatin Dynamics 4
- RNA Research and Splicing 3
- Extracellular vesicles in disease 3
- CRISPR and Genetic Engineering 3
-
- MicroRNA in disease regulation 3
- Co-authors
- Kankan Wang (7 shared papers)Robert F. Place (2 shared papers)Long-Cheng Li (2 shared papers)Vera Huang (2 shared papers)Guiting Lin (1 shared paper)Tom F. Lue (1 shared paper)Yi Qin (1 shared paper)Ji Wang (1 shared paper)
- Journals
- PLoS ONE (3 papers)Blood (2 papers)Frontiers of Medicine (2 papers)BMC Plant Biology (2 papers)Cancer Letters (2 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Xiaoling Wang
55 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 90
- Cancer Research 255
- Molecular Biology 546
- Hematology 89
- Nephrology 54
- Infectious Diseases 72
Countries citing papers authored by Xiaoling Wang
This map shows the geographic impact of Xiaoling Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Wang more than expected).
Fields of papers citing papers by Xiaoling Wang
This network shows the impact of papers produced by Xiaoling Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Wang. The network helps show where Xiaoling Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoling Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 154 | |
| 2 | 2021 | 97 | |
| 3 | 2017 | 81 | |
| 4 | 2024 | 75 | |
| 5 | 2020 | 64 | |
| 6 | 2005 | 51 | |
| 7 | 2016 | 50 | |
| 8 | 2023 | 49 | |
| 9 | 2009 | 48 | |
| 10 | 2015 | 42 | |
| 11 | 2012 | 41 | |
| 12 | 2015 | 39 | |
| 13 | 2009 | 32 | |
| 14 | 2014 | 32 | |
| 15 | 2016 | 29 | |
| 16 | 2021 | 29 | |
| 17 | 2021 | 28 | |
| 18 | 2010 | 26 | |
| 19 | 2017 | 26 | |
| 20 | 2015 | 24 |
About Xiaoling Wang
Xiaoling Wang is a scholar working on Molecular Biology, Cancer Research, Hematology, Oncology and Plant Science, having authored 58 papers that have together received 1.3k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (6 papers), Retinoids in leukemia and cellular processes (4 papers), Genomics and Chromatin Dynamics (4 papers), RNA Research and Splicing (3 papers), MicroRNA in disease regulation (3 papers), Extracellular vesicles in disease (3 papers), CRISPR and Genetic Engineering (3 papers) and Parasites and Host Interactions (2 papers). The work is most often cited by research in Cancer Research (255 citations), Molecular Biology (546 citations), Hematology (89 citations), Nephrology (54 citations) and Infectious Diseases (72 citations). Xiaoling Wang has collaborated with scholars based in China, United States and France. Frequent co-authors include Kankan Wang, Robert F. Place, Long-Cheng Li, Vera Huang, Guiting Lin, Tom F. Lue, Yi Qin, Ji Wang, Xiaojing Zhang and David W. Goodrich. Their work appears in journals such as PLoS ONE, Blood, Frontiers of Medicine, BMC Plant Biology and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.